Secondary Myelofibrosis market Growth Outlook 2024-2031: Demand, Trends & Forecast
Market overview Secondary Myelofibrosis market is estimated to grow at a CAGR of 6% during the forecast period 2024-2031. The Secondary Myelofibrosis market—covering drug therapies, bone-marrow transplantation options, supportive care and hospital/specialty services is seeing growing clinical and commercial attention as cases of underlying myeloproliferative neoplasms (notably...
0 Комментарии 0 Поделились 54 Просмотры 0 предпросмотр